FirmaIQ
Org.nr 933 977 439 2024 → 2025 Year-over-year analysis

AGOPRENE AS: årsregnskap 2025 vs 2024

Weaker earnings, fresh owner capital

approved 2026-05-29; registry 2026-06-23; journal 2026 575350

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2025 with 2024 for AGOPRENE AS. Net result -1 050 NOK → -610.9k NOK. Equity 21.4k NOK → 10.80m NOK.

On the constructive side: equity strengthened; cash rose; owners injected capital. Pressures included: operating result weakened; net result weakened.

Also worth watching: headcount (årsverk) changed. All figures are taken from the published annual accounts for AGOPRENE AS.

At a glance

Scorecard

Revenue
n/m 622.1k NOK
—
Operating result
-1 050 NOK -593.5k NOK
-56427.3%
Net result
-1 050 NOK -610.9k NOK
-58083.3%
Equity
21.4k NOK 10.80m NOK
+50341.7%
Cash
20.8k NOK 1.40m NOK
+6661.1%
Total assets
21.4k NOK 13.43m NOK
+62612.2%

What improved

  • ↑

    Equity strengthened

    Book equity 21.4k NOK → 10.80m NOK (equity ratio 100.0% → 80.4%). Calculated

  • ↑

    Cash rose

    Bank deposits 20.8k NOK → 1.40m NOK (+6661.1% YoY). Calculated

  • ↑

    Owners injected capital

    Paid-in equity rose 22.5k NOK → 13.20m NOK (+13.17m NOK). Reported fact

What deteriorated

  • ↓

    Operating result weakened

    Operating result -1 050 NOK → -593.5k NOK. Calculated

  • ↓

    Net result weakened

    Net result -1 050 NOK → -610.9k NOK. Calculated

Things to notice

  • ·

    Headcount (årsverk) changed

    Reported FTEs 0 → 3. Reported fact